Physician profile
Jose E Parodi
NPI 1922001908
$5,857.47
in general payments reported to CMS, 2019-2025
9 companies · $5,122 in 2025
The $5,122 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $260 · 2022: $187 · 2024: $70.69 · 2025: $5,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,620 · Travel and Lodging: $491 · Food and Beverage: $81.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,620.30 |
| Travel and Lodging | $491.16 |
| Food and Beverage | $81.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,320.09 | 2020-2025 | |
| Novo Nordisk INC | $208.45 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $186.34 | 2019 | |
| Abbvie INC. | $46.42 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.31 | 2024 | Gattex |
| Medtronic, INC. | $21.24 | 2024 | Venaseal |
| Axonics, INC. | $21.14 | 2024 | Axonics |
| Ethicon US, LLC | $14.32 | 2020 | |
| Endo Pharmaceuticals INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Parodi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.